Thema: US8036071004
SRPT, US8036071004
financial-2860753_1920.jpg - Foto: THN
Sarepta Therapeutics stock at EUR 16.77 as investor events near
Sarepta management will attend two healthcare conferences on November 9. The events put the rare-disease medicine company back on investors' calendars.
ad-hoc-news.de, heute 13:36 Uhr
SRPT, US8036071004
Leerink keeps USD 20.00 target for Sarepta Therapeutics ...
Leerink kept its Hold rating for Sarepta on October 16, 2026. Sarepta Therapeutics stock trades at EUR 17.09 on October 29, 2026.
ad-hoc-news.de, 29.10.26 13:40 Uhr
SRPT, US8036071004
TD Cowen keeps USD 17 target for Sarepta Therapeutics stock ...
TD Cowen keeps its USD 17 target on October 21, 2026. Sarepta Therapeutics stock costs EUR 16.18 on October 27, 2026 at Lang & Schwarz.
ad-hoc-news.de, 27.10.26 13:17 Uhr
SRPT, US8036071004
Sarepta schedules third-quarter results. TD Cowen targets ...
Second-quarter revenue fell 34.30 percent to USD 401.25 million. Sarepta Therapeutics stock has a USD 17.00 TD Cowen target.
ad-hoc-news.de, 25.10.26 13:55 Uhr
SRPT, US8036071004
TD Cowen keeps USD 17 target for Sarepta Therapeutics stock ...
Sarepta Therapeutics stock is at EUR 16.36 on October 22, 2026. Second-quarter revenue was USD 401.3 million, down 34.3 percent year over year.
ad-hoc-news.de, 22.10.26 14:21 Uhr
SRPT, US8036071004
H.C. Wainwright keeps USD 5 target for Sarepta Therapeutics ...
Second-quarter revenue reached USD 401.25 million, down 34.3 percent year over year. Sarepta Therapeutics stock trades at EUR 15.75 on October 20, 2026.
ad-hoc-news.de, 20.10.26 14:40 Uhr
SRPT, US8036071004
Sarepta presents 80 percent DM1 data for Sarepta Therapeutics ...
A USD 20.00 analyst target was set on October 15, 2026. Sarepta Therapeutics stock has a USD 1.8 billion market value.
ad-hoc-news.de, 18.10.26 13:12 Uhr
SRPT, US8036071004
Sarepta presents DM1 data as Sarepta Therapeutics stock ...
Sarepta presented SRP-1003 data on October 14, 2026, showing 80 percent knockdown. Sarepta Therapeutics stock costs EUR 15.03 on October 15, 2026.
ad-hoc-news.de, 15.10.26 13:52 Uhr
SRPT, US8036071004
Sarepta Therapeutics stock faces a USD 5.00 Sell target
Sarepta Therapeutics stock drew a USD 5.00 Sell target from HC Wainwright on October 6, 2026. Q2 revenue reached USD 401.251 million despite a GAAP loss.
ad-hoc-news.de, 07.10.26 07:02 Uhr
SRPT, US8036071004
HC Wainwright reiterates Sell for Sarepta Therapeutics stock ...
